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Abstract
The majority of HIV-1 infections worldwide are acquired via mucosal surfaces. However, unlike the vaginal mucosa, the issue
of whether the oral mucosa can act as a portal of entry for HIV-1 infection remains controversial. To address potential
differences with regard to the fate of HIV-1 after exposure to oral and vaginal epithelium, we utilized two epithelial cell lines
representative of buccal (TR146) and pharyngeal (FaDu) sites of the oral cavity and compared them with a cell line derived
from vaginal epithelium (A431) in order to determine (i) HIV-1 receptor gene and protein expression, (ii) whether HIV-1
genome integration into epithelial cells occurs, (iii) whether productive viral infection ensues, and (iv) whether infectious
virus can be transferred to permissive cells. Using flow cytometry to measure captured virus by HIV-1 gp120 protein
detection and western blot to detect HIV-1 p24 gag protein, we demonstrate that buccal, pharyngeal and vaginal epithelial
cells capture CXCR4- and CCR5-utilising virus, probably via non-canonical receptors. Both oral and vaginal epithelial cells are
able to transfer infectious virus to permissive cells either directly through cell-cell attachment or via transcytosis of HIV-1
across epithelial cells. However, HIV-1 integration, as measured by real-time PCR and presence of early gene mRNA
transcripts and de novo protein production were not detected in either epithelial cell type. Importantly, both oral and
vaginal epithelial cells were able to support integration and productive infection if HIV-1 entered via the endocytic pathway
driven by VSV-G. Our data demonstrate that under normal conditions productive HIV-1 infection of epithelial cells leading to
progeny virion production is unlikely, but that epithelial cells can act as mediators of systemic viral dissemination through
attachment and transfer of HIV-1 to permissive cells.
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Introduction
The majority of HIV-1 infections worldwide are acquired via
mucosal surfaces, predominantly across the female or male genital
tracts [1]. Heterosexual transmission accounts for the majority of
new HIV-1 infections, and both men and women have been
shown to have detectable HIV-1 in seminal fluid and cervicovag-
inal secretions [2–4]. Studies have shown that cell-free [5]and cell-
associated [6] HIV-1 can establish mucosal infection and macaque
and human studies indicate that transmission is facilitated by the
presence of HIV-1 target cells (dendritic cells, Langerhans cells,
CD4+ T cells and macrophages) in the ectocervix and vagina as
well as in the endocervix and uterus [7–21]. In contrast, HIV-1
transmission through the oral mucosa is thought to be uncommon
[22–27]. We and others have shown that several mechanisms may
account for the lack of HIV-1 transmission across the oral mucosa,
including neutralizing antibodies in seropositive individuals and
innate anti-HIV inhibitory factors in saliva and/or epithelium
[28–32]. However, studies in primates indicate that oral transmis-
sion can occur since non-traumatic oral exposure to SIV results in
regional dissemination followed by systemic infection [33–36].
Therefore, although the oral epithelium may present a barrier to
HIV-1 transmission via direct infection, it may also be a conduit
for viral entry. This is particularly important given the occurrence
of viral transmission in nursing infants and during oro-genital
contact in adults.
Entry of HIV-1 into permissive host cells requires expression of
the receptor CD4 and a fusion co-receptor (chemokine receptors
CCR5 (R5-tropic) or CXCR4 (X4-tropic)) [37]. However, the vast
majority of reports indicate that epithelial cells do not express CD4
[38–42] and express CCR5 and CXCR4 at either undetectable or
very low levels [38,41,43–47], although data for CXCR4 surface
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expression is somewhat varied [45,48]. Despite these receptor
dependencies, HIV-1 may also infect CD42 cells and may thus
utilize several alternative receptor mechanisms for binding and
entry into cells. Besides binding to canonical entry receptors, the
viral envelope protein gp160 (gp120 and gp41) also binds to
several other cell-surface molecules including DC-SIGN (dendritic
cell-specific intercellular adhesion molecule-3-grabbing non-inte-
grin) [49,50], GalCer (glycosphingolipid galactosylceramide) [51–
53], and heparan sulphate proteoglycans (HSPGs) such as
syndecan-1 [54,55]. GalCer and HSPGs are commonly expressed
on epithelial cells and may promote HIV-1 binding and transport
across the oral and vaginal epithelium [32,46–48,55]. Importantly,
there is a preference for R5-tropic viral transmission across
mucosal surfaces [56], but a full and satisfactory explanation for
this has not yet been provided.
One mechanism of HIV-1 transmission across the mucosa is
thought to occur through sequestration of the virus by epithelial
cells, followed by transfer to permissive cells to establish a primary
infection [7–10,12–14,16–18,47,57]. Similarly, HIV-1 binding to
epithelial cells may directly impair barrier integrity, thus
facilitating entry [58,59]. Indeed, the outermost epithelial layers
of the ectocervix and vagina lack tight junctions and are
permeable to high molecular weight immunological mediators
[60] and, therefore, possibly to virions. However, the fundamental
issue of whether epithelial cells can be productively infected with
HIV-1 remains controversial. Whilst some studies support the view
that HIV-1 can integrate into the vaginal epithelial genome and
produce progeny virus [5,45,61–64], others discount this view
[18,20,47,55]. Likewise, in the oral cavity, proviral DNA has been
detected in oral epithelial cells [65] and the presence of HIV-1 gag
RNA has been demonstrated in both buccal cells [66,67] and oral
biopsies [67,68]. Furthermore, using primary gingival epithelial
cells, one study showed susceptibility to R5 but not X4 tropic viral
strains in a CD4-independent manner [69], whilst another study
showed X4 rather than R5 susceptibility [38], with epithelial cells
being able to secrete infectious virus. Primary epithelial cells
isolated from adenoids, palatine tonsils and salivary glands may
also be productively infected with HIV-1 [69–74]. However,
others have found no evidence of productive HIV-1 infection in
oral epithelial cells [40,41]. Rather, HIV-1 is thought to be
preferentially sequestered in cytosolic endocytic compartments or
transferred to permissive cells after transcytosis across epithelial
cells or traverse the epithelial barrier dissimulated in infected cells
to establish a primary infection [1,41,46,47,55,75–80]. Thus, the
literature remains ambiguous as to whether HIV-1 proviral DNA
integrates into the epithelial cell genome and whether productive
infection ensues. Notably, a mechanism has been described
recently to explain the difference between oral transmission in
adults and infants using ex vivo cell models, whereby adult
epithelium coats HIV-1 particles with human b-defensins 2 and
3, rendering the cell-free virus less infectious [81]. The same group
also established that the paucistratified fetal and infant oral
epithelium was more permissive to HIV-1 transcytosis as
compared with healthy multistratified adult oral epithelium [82].
Given the ambiguous literature on this fundamentally important
topic, we aimed to compare oral and vaginal epithelial cells using
identical assay systems to determine whether cell-free HIV-1
binds, enters and integrates into epithelial cells, whether produc-
tive infection ensues, and whether sequestered infectious virus can
be transferred to permissive cells. We utilized epithelial cell lines
representative of two oral sites that are rarely investigated with
regard to oral transmission but are one of the first cell types that
are likely to come into contact with HIV-1 in the oral cavity and
compared them with female genital epithelium. Buccal (TR146),
pharyngeal (FaDu) and vulvo-vaginal (A431) epithelial cells, all
from stratified squamous cell origin, were utilized to permit
convenient and direct comparisons to be made with regard to
HIV-1 life cycle events. We demonstrate that oral and vaginal
epithelial cells were able to capture X4 and R5 virus but that
integration of the viral genome into epithelial cell DNA and de novo
virus production were not detected. However, VSV-G-packaged
HIV-1 was replication competent in all epithelial cell lines.
Notably, the three epithelial cell types were able to transfer
infectious virus to permissive cells either directly or after
transcytosis of HIV-1 across the epithelium, which in vivo would
permit infection of immune cells in the sub-mucosa and
dissemination of HIV-1 in the body.
Methods
Ethics Statement
Primary epithelial cells (gingival) were obtained from wisdom
tooth extractions and were kindly provided by Maxine Partridge
and collection approved by the Guy’s Research Ethics Committee.
Informed written consent was obtained from each participant.
Cell lines, primary cells, viruses and virus-like particles
Human oral buccal (TR146) and pharyngeal (FaDu) and
vulvovaginal (A431) carcinoma cell lines and 293T (renal
epithelial) cells were obtained from the American Type Culture
Collection and European Collection of Cell Cultures (ECACC).
A431 epithelial cells have different reported origins (vaginal
epithelial or epidermal) but are routinely used to represent the
vaginal mucosa [83–87]. Human glioma cells (NP2) expressing
human CD4 and CXCR4 or CCR5 have been previously
described [88]. The following reagents were obtained through
the AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH: TZM-bl cells (catalogue no. 8129), PM-1
cells (catalogue no. 3038), C8166 T cells (catalogue no. 404),
JTLRG-R5 (catalogue no. 11586) and HIV-1 molecular clones
pYU2 (R5-utilizing, catalogue no. 1350) and pLAI.2 (X4-utilizing,
catalogue no. 2532). Peripheral blood mononuclear cells (PBMCs)
were isolated from apheresis cones (National Blood Service
Tooting, London, UK) by centrifugation over a Ficoll-Paque
density gradient (GE-Healthcare UK Ltd, Little Chalfont, UK).
The HIV-1 gag-pol expression vector p8.91 and the vesicular
stomatitis virus envelope protein (VSV-G) expression vector
pMDG were kindly provided by Didier Trono (University of
Geneva, Switzerland). The HIV gp160 envelope vectors (pHXB2
(X4), pYU2 (R5) and pSVIII 89.6 (dual tropic)) were a gift from
Professor Greg Towers, University College London. The retroviral
packaging vector pCSGW encoding green fluorescent protein
(GFP) was a kind gift from Adrian Thrasher, Institute of Child
Health, University College London, UK. All cell lines were
maintained in Dulbecco’s Modified Eagle’s Medium (DMEM,
PAA) supplemented with 10% fetal bovine serum (FBS) (PAA),
100 U of penicillin per mL, and 100 mg of streptomycin per mL
(PAA) at 37uC and 5% CO2. NP2 cells were additionally
supplemented with 1 mg/mL of G418 (Invitrogen) and 1 mg/
mL of puromycin (Invitrogen).
Virus preparation
Viral vectors used for production of VSV-G and HIV gp160
pseudotyped HIV were prepared by transient transfection of 293T
cells using a protocol adapted from Besnier et al. [89]. Briefly,
293T cells were seeded at 95% confluency in a 10 cm2 dish and
the following day cells were transfected with 3 mg each of pMDG
and p8.91 and 4.5 mg of pCSGW using the polyanionic
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transfection reagent Jet PEI (Polyplus Transfection) according to
the manufacturer’s instructions. After 24 h the media was replaced
and 48, 72 and 96 h post-transfection virion-containing culture
supernatants were harvested and filtrated through a 0.45 mm pore
size membrane and stored in aliquots at –80uC until required.
Production of infectious stocks of live virus was performed by
transient transfection of 293T cells as described above, with 5 mg
of the infectious molecular clone pLAI.2 (X4) and or pYU2 (R5)
used per transfection. For trypsin sensitivity experiments and
detection of integration into epithelium, YU2 virus was grown in
NP2-R5 and JLTRG-R5 cells while LAI virus was grown in
C8166 cells for 1- 2 weeks with addition of fresh medium until cells
showed cytopathic effects and were then harvested and frozen in
aliquots.
Virus titration
Infectious virus stock (LAI and YU2) titers were determined by
plaque assay. Briefly, TZM-bl cells (16104 cells/well) were
cultured overnight (96-well plates) and incubated with eight
replicates of ten serial dilutions (0.5 log) of virus stock in a total of
100 mL growth media per well. After 48 h, virus supernatant was
removed and the cells were fixed with 0.05% glutaraldehyde for
5 min at room temperature and washed twice with phosphate-
buffered saline (PBS). Expression of b-galactosidase was deter-
mined by staining cells with X-Gal stain [1 mg/mL X-Gal in
5 mM KFe4(CN6) 3H2O, 5 mM KFe3(CN6) 3H2O, and 1 mM
MgCl2] and incubating culture plates at 37uC for 2 h. Virus
infectivity was estimated as plaque forming units (PFU) per mL.
Titration of VSV-G pseudotyped HIV-1 and HIV gp160
pseudotyped HIV-1 was carried out using 293T cells or NP2
cells, respectively. Cells were seeded at 1 x 105 cells/well (24-well
plates) and cultured overnight at 37uC. Serial dilutions (1:2) of
virus supernatant were applied to the cells (500 mL) and incubated
overnight. The following day the media was exchanged and 48 h
after transduction with virion-containing culture supernatants the
percentage of GFP-expressing cells was determined by flow
cytometry using the FACSCanto machine (BD Biosciences). Data
was analyzed with FACSDiva software and WinMDI (copyright
1993–2000 Joseph Trotter http://facs.scripps.edu) to calculate the
infectious units per mL.
HIV-1 receptor expression by quantitative reverse
transcription-PCR
RNA was isolated from resting TZM-bl, TR146, FaDu and
A431 cells using GenElute Mammalian Total RNA Miniprep Kit
(Sigma), followed by treatment with Turbo DNA free DNAse
(Ambion) according to the manufacturer’s instructions. All samples
were confirmed DNA free prior to analysis. cDNA was synthesized
from 1 mg of RNA using HIV reverse transcriptase (Ambion)
according to the manufacturer’s instructions. Primers were
obtained from RTPrimerDB (http://medgen.ugent.be/
rtprimerdb/) and PrimerBank (http://pga.mgh.harvard.edu/
primerbank) [90,91]. Gene expression of CD4, CCR5, CXCR4,
DC-SIGN, SDC-1 (syndecan-1) and SDC-4 (syndecan-4) was
quantified by real-time PCR using SYBR Green JumpStart Taq
Ready Mix (Sigma) with 4 pmol primers and 1 mL cDNA in 10 mL
reactions on the Corbett Research Rotor-Gene 6000 (Qiagen)
using the following cycling parameters: 95uC for 3 min; followed
by 95uC for 3 s, annealing for 10 s and extension for 20–30 s for
40 cycles. Data was analyzed with Corbett Research Rotor-Gene
6000 Series Software 1.7 using the two standard curve method
with b-actin used as the normalizer gene. Primer sequences,
annealing and extension temperatures are listed in Table 1.
HIV-1 receptor expression by flow cytometry
TZM-bl, NP2-X4, NP2-R5, TR146, FaDu and A431 resting
cells were washed with PBS and incubated with 0.02% (W/V)
EDTA for 5–30 min. Detached cells were washed thoroughly with
PBS supplemented with 1% BSA and 0.01% azide (wash buffer),
and resuspended at 16106 cells in 1 mL wash buffer. To identify
surface expressed HIV-1 receptors and co-receptors, 100 mL of
cells were incubated at room temperature for 1 h with mouse anti-
human CD4 (1:4, catalogue no. 724), CCR5 (1:20, catalogue
no. 4090), CXCR4 (1:80, catalogue no. 4083), DC-SIGN (1:100
catalogue no. 6884) monoclonal antibodies (all obtained from the
AIDS Research and Reference Reagent Program), GalCer (1:200,
anti-galactocerebroside, Millipore) or heparan sulfate proteoglycan
(1:200, Millipore) monoclonal antibodies. Primary antibodies were
detected with goat anti-mouse IgG conjugated with fluorescein
isothiocyanate (FITC) (Jackson ImmunoResearch). After thorough
washing, cells were fixed in 200 mL 4% formaldehyde and the
percentage of FITC-expressing cells was determined by flow
cytometry.
Detection of HIV-1 binding and replication by Western
Blot
TR146, FaDu, A431 and TZM-bl cells were seeded at 5 x 105
cells per well and the following day incubated with YU2 (R5) or
LAI (X4) virus at a multiplicity of infection (MOI) of 0.2. After
overnight incubation at 37uC the cells were washed to remove
unbound virus. Cells were harvested in 250 mL 1x RIPA buffer
[50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100,
1% sodium deoxycholate and 0.1% SDS, supplemented with Halt
complete protease inhibitor cocktail (Perbio Science)], placed on
ice for 30 min, and stored at 280uC until required. Total protein
lysates (mammalian and viral) were normalized for protein content
using the bicinchoninic acid (BCA) assay (Pierce) and separated
using 12% SDS-PAGE gels. Proteins were transferred to PVDF
membranes, probed with anti-HIV-1 gag monoclonal antibody
recognizing p24 and p55 isoforms (catalogue no. 6457)) and
secondary goat anti-mouse IgG horseradish peroxidase (HRP)-
conjugated antibody (Jackson ImmunoResearch), before develop-
ing using Immobilon-ECL (Millipore). a-actin was used as a
loading control.
Detection of HIV-1 binding and packaged viral RNA by
PCR
TR146, FaDu, A431 and TZM-bl cells were seeded at 5 x 105
cells per well and the following day exposed to YU2 (R5) or LAI
(X4) virus at an MOI of 0.2. After overnight incubation at 37uC
the cells were washed to remove unbound virus. Total RNA was
isolated as above and confirmed DNA free prior to analysis. Equal
amounts of total RNA were used to detect packaged viral RNA by
first synthesizing cDNA using Superscript cDNA Synthesis Kit
(Invitrogen) and an HIV-1 specific primer (5’-GTC ATG AAA
CAA ACT TGG C-3’). A 2 mL aliquot of cDNA was then
subjected to nested PCR using primers to amplify a 2 kb fragment
of the HIV pol gene. First round PCR was performed in a 20 mL
reaction containing 1x PCR buffer, 100 mM dNTP’s, 1.5 mM
MgSO4, 2.5 U Taq polymerase (New England Biolabs) and
10 pmol of each primer (Forward: 5’-AAT GAT GAC AGC
ATG TCA GGG AGT-3’; Reverse: 5’-AGT CTT TCC CCA
TAT TAC TAT GCT TTC-3’). Cycle parameters were as
follows: 95uC for 5 min; 94uC for 10 s, 55uC for 30 s, and 72uC
for 1 min for 30 cycles; and an extension of 72uC for 10 min. For
subsequent nested PCR, 1 mL of the first round PCR reaction was
used as a template to amplify an internal region of the pol gene and
Epithelial Cells Binding and Transfer Infectious HIV-1
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was performed in a 10 mL reaction containing 1x SYBR Green
JumpStart Taq Ready Mix (Sigma), and 3 pmol of each primer
(Forward: 5’-TTC TTC AGA GCA GAC CAG-3’; Reverse: 5’-
ACT TTT GGG CCA TCC ATT-3’). Cycle parameters were
95uC for 3 min; followed by 95uC for 1 min, 55uC for 30 s, and
72uC for 1 min for 35 cycles; and an extension of 72uC for 10 min.
PCR products were resolved on a 2% agarose gel and visualized
by ethidium bromide staining.
Whole virus binding and trypsin sensitivity
TZM-bl, TR146, FaDu and A431 cells (5 x 104) were incubated
with either YU2 (R5) or LAI (X4) virus at an MOI of 5 overnight
at 4uC. Cells were washed three times with PBS and blocked in
PBS/10% BSA for 10 min at room temperature. To determine
whether HIV-1 binding was trypsin sensitive, prior to blocking,
cells were treated with trypsin (0.05%)-EDTA (0.02%) (PAA, UK)
for 5 min at 37uC. Cells were gently removed by scraping and
labeled with HIV-1 gp120 monoclonal antibodies F425 A1g8 and
F425 B4e8 (1:200) (AIDS Research and Reference Reagent
Program) followed by Cy5-conjugated AffinityPure goat anti-
human IgG secondary antibody (1:400) (Jackson ImmunoRe-
search), each for 30 min at 4uC. Cells were washed three times
with PBS, resuspended in 4% formaldehyde and subjected to flow
cytometry. Binding percentages for whole virus were calculated as
increased Cy5 shift of HIV-1 infected labelled cells from
uninfected labelled cells. Given the higher background with a
new batch of F425 B4e8 antibody, binding percentages for the
trypsin sensitivity data were calculated as increased Cy5 shift
relative to HIV-1 infected secondary alone labelled cells.
Detection of HIV-1 integration by primer-probe Alu-LTR
PCR assay
To determine whether HIV DNA was able to integrate into
epithelial cells a real-time PCR assay was performed with HIV-1
LTR and human Alu-specific primers with a U5 specific probe as
previously described [92]. TR146, FaDu, A431 and PM-1
(control) cells were seeded at 5 x 105 cells per well and the
following day exposed to YU2 (R5) or LAI (X4) virus, pre-treated
with RNAse-free DNAse (Roche, UK) at 37uC for 1 h with 4 mM
MgCl2. MOI’s ranged from 1 to 140. Heat-inactivated virus (60uC
for 1 h) without DNAse treatment was used as a DNA
contamination control. Cells and virus were incubated for 48 h
at 37uC, after which cells were washed three times with PBS before
DNA was extracted using the GenElute Mammalian Genomic
DNA Miniprep Kit (Sigma, Poole, UK) according to the
manufacturer’s instructions with Proteinase K digestion for
20 min. Isolated DNA samples were digested with DpnI (New
England Biolabs, UK) to degrade any plasmid DNA contaminant.
DNA was then quantified by Nanodrop and either 50 ng or
100 ng DNA was analysed by real-time PCR on a Rotorgene 6000
(Qiagen, UK) using primers 0.2 M MH535 forward (59-AAC-
TAGGGAACCCACTGCTTAAG-39) and 0.8 M reverse SB704
(59-TGCTGGGATTACAGGCGTGAG-39) with 0.2 M probe P-
HUS-SS1 (59FAM-TAGTGTGTGCCCGTCTGTTGTGTGA-
C-TAMRA-39) using Jumpstart Ready Mix (Sigma, Poole, UK) in
10 mL reactions. For each PCR reaction the same concentration of
DNA was used for all samples isolated from individual cell lines.
Samples were denatured for 10 min followed by 60 cycles of 94uC
for 15 s, 60uC for 30 s and 72uC for 60 s. DNAse-treated virus
exposed samples were compared with heat-inactivated virus
exposed samples. Positive integration events were taken as a lower
Ct in the DNAse treated virus exposed sample than the heat-
inactivated virus control.
Productive viral infection by detection of spliced HIV-1
tat by PCR
TR146, FaDu, A431 and TZM-bl cells were seeded at 5 x 105
cells per well and the following day incubated with YU2 (R5) or
LAI (X4) virus at an MOI of 0.2. After overnight incubation at
37uC unbound virus was removed by washing and total RNA
isolated (GenElute Mammalian Total RNA Miniprep Kit; Sigma).
Genomic DNA was removed with Turbo DNAse free (Ambion)
according to the manufacturer’s instructions and samples were
confirmed DNA free prior to analysis. Equal amounts of total
RNA was used to synthesize viral cDNA transcripts using the
HIV-specific oligo ART-7 59- TTC TAT TCC TTC GGG CCT
GTC G -39. A 1 mL aliquot of cDNA was then subjected to PCR
using primers spanning the tat1 and 2 exon junctions (tat-junction
forward: 59- TAG ATC CTA GAC TAG AGC CC-39 and tat-
junction reverse 59- TTG GGA GGT GGG TCT GAA ACG-39)
in a 20 mL reaction containing 1x PCR buffer, 100 mM dNTP’s,
1.5 mM MgSO4, 2.5 U Taq polymerase (New England Biolabs)
and 10 pmol of each primer. Cycle parameters were as follows:
95uC for 5 min; followed by 94uC for 10 s, 55uC for 30 s, and
72uC for 1 min for 35 cycles; with a final extension of 72uC for
10 min. PCR products were resolved on a 2% agarose gel and
visualized by ethidium bromide staining.
HIV-1 integration and productive infection using
pseudotyped virus-like particles
TR146, FaDu, A431, NP2-R5 and NP2-X4 cells were seeded at
1 x 105 cells per well and cultured overnight at 37uC. Serial
dilutions (1:2) of HIV-1 gp160 pseudotyped (X4, R5 and dual
tropic) and VSV-G pseudotyped HIV-1 were applied and
Table 1. Primer sets detecting gene expression of HIV-1 associated receptors.
Gene Primer Sequence
Annealing
temp. (6C)
Extension
temp. (6C)
Product
(bp)
CD4 Forward Reverse 59- ACTAAAGGTCCATCCAAGCTGA —39 59- GCAGTCAATCCGAACACTAGCA —39 60 75 151
CCR5 Forward Reverse 59- TGGACCAAGCTATGCAGGTG —39 59- CGTGTCACAAGCCCACAGAT —39 58 75 240
CXCR4 Forward Reverse 59- CCTCATCCTGGCTTTCTTCG —39 59- GAATGTCCACCTCGCTTTCC —39 60 75 285
DC-SIGN Forward Reverse 59- TCAAGCAGTATTGGAACAGAGGA —39 59- CAGGAGGCTGCGGACTTTTT —39 60 75 136
Syndecan-1 Forward Reverse 59- TGAAACCTCGGGGGAGAATAC —39 59- GGTACAGCATGAAACCCACC —39 60 75 171
Syndecan-4 Forward Reverse 59- CAGGGTCTGGGAGCCAAGT —39 59- GCACAGTGCTGGACATTGACA —39 58 72 129
b-actin Forward Reverse 59- CATGTACGTTGCTATCCAGGC —39 59- CTCCTTAATGTCACGCACGAT —39 58 75 250
doi:10.1371/journal.pone.0098077.t001
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incubated overnight at 37uC. HIV-1 integration and de novo virus
protein production were determined by the presence of GFP-
expressing cells by flow cytometry. To inhibit HIV-1 specific GFP
expression, infections were also carried out in the presence of
500 mM of the HIV-1 reverse transcriptase inhibitor AZT (NIH
AIDS Reagent Program Cat no. 3485).
Detection of de novo HIV-1 production by indicator cell
infection
TR146, FaDu, A431 and TZM-bl cells were seeded at 5 x 105
cells per well and the following day cultured with YU2 (R5) or LAI
(X4) virus at an MOI of 0.2. After overnight incubation at 37uC
the cells were extensively washed with HBSS (Invitrogen) to
remove unbound virus. Fresh media was applied to the cells and
the plates were incubated at 37uC for up to 7 days to allow any de
novo-produced infectious virus to be released into the medium.
Culture medium (potentially containing infectious virus) was then
applied to 3 x 105 TZM-bl indicator cells and incubated for a
further 24 h at 37uC. Cells were fixed, washed twice with PBS and
stained for b-galactosidase expression with X-Gal stain. Individual
wells were visualized by light microscopy at 100 X magnification.
HIV-1 transfer assay
FaDu, TR146, A431 and TZM-bl cells were seeded at 1 x 105
cells and the following day exposed to YU2 (R5) or LAI (X4) virus
at an MOI of 0.2. After overnight incubation at 37uC the cells
were thoroughly washed in HBSS to remove any unbound virus.
Controls included FaDu and TR146 and A431 cells without the
addition of virus. TZM-bl cells (3 x 105) were then overlaid onto
the epithelial cells and the plates incubated for a further 48 h at
37uC. Cells were fixed and stained for b-galactosidase expression
with X-Gal stain. Individual wells were photographed by light
microscopy at 100 X magnification.
HIV-1 transcytosis across epithelium
TR146, FaDu and A431 cells were seeded at 5 x 104cells per
Millipore transwell 24-well inserts (membrane pore size 0.4 mm)
and the following day (after confluency was reached) incubated
with YU2 (R5) or LAI (X4) virus in phenol red-free medium at an
MOI of 0.2 containing 2.3 mg/mL of dextran blue [59,93]. After
4 h incubation at 37uC, the cells in inserts were thoroughly washed
with PBS to remove any unbound virus. Controls included
epithelial cells without the addition of virus. The transwell inserts
were then overlaid upon a confluent monolayer of TZM-bl cells in
24-well plates (the epithelial cells were separated from the TZM-bl
cells by the transwell membrane preventing cell-cell contact).
Plates were incubated for a further 48 h at 37uC to allow HIV-1 to
transcytose across the epithelial cells and through the membrane
pores to infect the underlying TZM-bl cells. TZM-bl cells were
fixed, stained for b-galactosidase expression with X-Gal stain, and
counted using light microscope at 100 X magnification.
Statistical analysis
Where shown, the data were analyzed by ANOVA using
SigmaPlot 12.5 (Systat Software Inc). A p value of less than 0.05
was taken to be significant.
Results
Expression of HIV-1 receptors in epithelial cells
We first analyzed the gene expression levels of canonical (CD4,
CCR5, CXCR4) and non-canonical (DC-SIGN and HSPG’s,
excluding GalCer as this non-protein moiety cannot be
investigated by gene expression) HIV-1 receptors in epithelial
cells by quantitative PCR (Figure 1). This demonstrated the
absence or minimal expression of CD4, CCR5 and CXCR4 in
both TR146 (buccal) and FaDu (pharyngeal) cells compared with
PBMCs, (P,0.001). Similar data were obtained with the A431
(vaginal) cells but notably CD4 mRNA was detected, albeit at
levels approximately 110-fold lower than PBMCs (P,0.001).
Control TZM-bl cells exhibited greater (P,0.001) expression of all
three genes relative to oral and vaginal cell lines but still lower
expression of CD4 (10-fold lower) and CXCR4 (200-fold lower)
than PBMCs (P,0.001). Expression of CCR5 in TZM-bl cells was
greater than 10-fold higher than PBMCs (P,0.001). In all three
cell types DC-SIGN was minimally expressed but HSPG
syndecan-1 was highly expressed, particularly in A431 cells (P,
0.05). The only major difference observed between the epithelial
cell types was the expression of the HSPG syndecan-4 in FaDu
and A431 cells, which was undetectable in TR146 cells (P,0.05).
We next determined the surface expression (% positive cells) of
CD4, CCR5, CXCR4, DC-SIGN, GalCer, and HSPG’s on
epithelial cells by flow cytometry (Figure 2 and Figure S1). All
three cell lines expressed undetectable levels of CD4 and very low
levels of CCR5 and CXCR4 (,6–8%) compared with control
TZM-bl cells, which are HeLa cell derivatives engineered to
express CD4 (32%), CCR5 (82%) and CXCR4 (85%). NP2 cells
expressing either CCR5 (85%) or CXCR4 (88%) were also used as
positive controls and expressed high levels of CD4 (50–60%). With
regard to non-canonical receptors, both TR146 and FaDu oral
cells expressed similar amounts of DC-SIGN (6–8%) and HSPG’s
(6–10%) but FaDu cells expressed greater amounts of GalCer than
TR146 cells (25% and 15%, respectively). The similar amounts of
surface HSPG’s expressed on TR146 and FaDu cells appears to be
in contrast to the differences in gene expression data for syndecan-
4 (Figure 1); however, this was expected since the detecting
antibody recognizes other HSPG’s including syndecan-1, which is
highly expressed in both TR146 and FaDu cells (Figure 1).
Notably, A431 vaginal cells expressed significantly greater surface
levels of GalCer (,75%) and HSPG’s (35%) compared with the
oral cells (TR146 GalCer 15.6% (P,0.001), HSPG ,10.3% (P,
0.05); FaDu GalCer 25.5% (P,0.01), HSPG 6.3% (P,0.05))
(Figure 2 and Figure S1). TZM-bl cells expressed low levels of DC-
SIGN (14%), GalCer (14%) and HSPG’s (7%). Likewise NP2-X4
and –R5 cells expressed low levels of DC-SIGN (5–20%), but
higher levels of GalCer (25–50%).
HIV-1 binding to epithelial cells
We next determined whether HIV-1 can be captured by oral
and vaginal epithelial cells. TR146, FaDu, A431 and TZM-bl cells
were incubated overnight with cell free YU2 (R5) or LAI (X4)
infectious virus. After extensive washing, the presence of attached
virus was determined using three separate approaches.
First, total protein was isolated and the presence of HIV-1 p24
gag protein determined by immunoblot analysis. p24 was present
in TR146, FaDu and A431 protein lysates at levels similar to that
found with TZM-bl cells, indicating that both R5 and X4 virus are
captured by both oral and vaginal epithelial cells (Figure 3A). We
confirmed that R5 and X4 virus are also captured by primary oral
epithelial cells (gingival) (Figure 3A). Given the identical HIV-1
binding data between primary and carcinoma epithelial cells, all
other experiments were performed with TR146, FaDu and A431
cells.
Second, using a more quantitative approach, the presence of
immobilized virus on the surface of TR146, FaDu and A431 cells
was determined by flow cytometry using a Cy5-labeled secondary
antibody to detect a human monoclonal primary (F425 B4e8) that
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detected HIV-1 gp120. Both R5 and X4 virus was detected on
TR146, FaDu and A431cells demonstrating direct binding of
infectious virus to both oral and vaginal epithelial cells (Figure 3B).
However, FaDu cells bind significantly more of both R5 (27%) and
X4 (31%) virus than TR146 (R5 4%, (P,0.05), X4 5% (P,0.05))
and A431 (R5 4.5% (P,0.05), X4 5.5%, (P,0.05)) cells but to a
lesser degree than control TZM-bl cells (62–68%). A second
monoclonal primary antibody (F425 A1g8) showed similar binding
to the epithelial lines as F425 B4e8 (Figure 3B and Figure S2).
Third, we also determined the presence of captured virus
through the detection of packaged HIV RNA by amplification of
the HIV-1 pol gene using nested PCR. This approach was used to
confirm the p24 protein and whole virus binding data; therefore,
we performed this experiment using R5 virus only. Amplification
of the HIV-1 pol gene indicated the presence of R5 virus on
TR146, FaDu and A431 cells in addition to TZM-bl cells
(Figure 3C). The Western blot (Figure 3A) and PCR (Figure 3C)
data are qualitative and may not reflect differences in the
efficiency of R5 and X4 HIV-1 binding to TR146, FaDu or
A431 cells, which was more apparent when using the quantitative
flow cytometry approach (Figure 3B).
Finally, we determined whether binding (performed at 4uC) of
both R5 and X4 virus to TR146, FaDu and A431 cells was trypsin
sensitive. Notably, R5 binding to all three cell lines was highly
sensitive to trypsin with a reduction of between 73–97% binding,
whereas X4 virus appeared more trypsin resistant, especially in
TR146 and A431 cells where viral binding was reduced only by
33% and 16%, respectively (Figure 3D). This suggests that R5
virus interacts predominantly with trypsin-sensitive protein moi-
eties on epithelial cells to mediate binding, whilst X4 virus also
utilizes trypsin-insensitive or additional non-protein moieties.
Figure 1. Basal HIV-1 receptor mRNA expression in resting epithelial cells. TR146, FaDu, A431 and TZM-bl cells were examined for mRNA
expression of CD4, CCR5, CXCR4, DC-SIGN and the HSPG’s syndecan-1 and -4 by quantitative RT-PCR. Data are presented as mRNA transcripts
(arbitrary units) normalized to b-actin in a minimum of three independent experiments. PBMCs showed significantly higher expression of CD4, CCR5
and CXCR4 than oral (TR146 and FaDu) or vaginal (A431) cell lines. A431 cells show significantly higher expression of SDC-1, whilst FaDu and A431
show significantly higher expression of SDC-4 than TR146. Bars indicate 6 standard deviation from the mean. *** = P,0.001, * = P,0.05.
doi:10.1371/journal.pone.0098077.g001
Figure 2. Basal HIV-1 receptor surface expression in resting
epithelial cells. TR146, FaDu, A431, TZM-bl and NP2-R5 and –X4
expressing cells were examined for surface expression of CD4, CCR5,
CXCR4, DC-SIGN, GalCer and HSPG’s by flow cytometry using
monoclonal primary antibodies specific to each receptor with a FITC-
labeled secondary antibody. HSPG’s were not analyzed in NP2-R5 or -X4
expressing cells. Data are presented as percentage of cells expressing
each receptor in a minimum of three independent experiments. Bars
indicate 6 standard error of the mean. *** = P,0.001, ** = P,0.01,
* = P,0.05.
doi:10.1371/journal.pone.0098077.g002
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Taken together, the data demonstrate that both R5 and X4 virus
bind directly to buccal, pharyngeal and vaginal epithelial cells,
although differences may exist in the surface moieties used for
attachment.
HIV-1 mRNA transcription and de novo viral protein
production
Given that HIV-1 was able to bind to TR146, FaDu and A431
cells, we hypothesized that epithelial cells may support productive
viral infection. To investigate this we utilized four different
approaches.
First, we used a PCR-based system to detect spliced HIV-1 tat
mRNA in the target epithelial cells 24 h post-infection with
infectious R5 and X4 virus. The presence of high levels of spliced
tat mRNA indicates HIV-1 integration and de novo production of
viral mRNA transcripts, which in permissive cells is representative
of a productive HIV-1 infection. However, we found that spliced
tat mRNA was only detected in control TZM-bl cells but not in
TR146, FaDu or A431 cells (Figure 4A).
Second, we assessed protein lysates of TR146, FaDu, A431 and
TZM-bl cells for p55 gag protein by Western blot 24 h post-
infection with R5 or X4 virus. Detection of p55 gag protein would
only be observed if de novo viral protein production had occurred.
Figure 4B shows p55 gag protein expression only in the control
TZM-bl cells but not in the TR146, FaDu or A431 epithelial cells.
Third, since most assays were undertaken 24–48 h post-
infection with HIV-1, we also assessed for HIV-1 progeny after
day 4 and 7 in case an extended time period was required to
establish a productive infection in oral and vaginal epithelial cells.
Therefore, after addition of infectious R5 and X4 virus to TR146,
FaDu and A431 for 24 h, the cells were thoroughly washed and
the medium replenished for up to 7 days. Culture supernatants
taken at day 4 and 7 (potentially containing new viral progeny) and
Figure 3. Different methods used to detect HIV-1 R5 and X4 binding to epithelial cells. (A) Post-lysis detection of p24 gag protein by
Western blotting. Primary (gingival) epithelial cells, TR146, FaDu, A431 and TZM-bl cells were incubated overnight (16–24 h) with cell free YU2 (R5) or
LAI (X4). After extensive washing to remove unbound virus, normalised total protein lysates were separated by SDS-PAGE and probed for HIV p24
using a-actin as a loading control. (B) Detection of immobilized virus on the cell surface by flow cytometry. Epithelial cells were incubated overnight
with cell free virus. Bound virus was detected using a Cy5-labeled anti-human secondary antibody to detect HIV-1 gp120 primary monoclonal on the
APC channel. Electronic gates were set around an unlabelled cell control, this area is then set as zero and any cells shifted to the right of the gate are
deemed positive. To determine amount of virus bound, virally exposed, labelled cell percentages are subtracted from the uninfected (unexposed)
labelled control cell percentages to obtain the % fluorescence values shown. Data are representative of four independent experiments and bars
indicate 6 standard deviation from the mean. (C) Detection of packaged HIV R5 RNA by amplification of the HIV-1 pol gene using nested PCR. Total
RNA was extracted from TR146, FaDu, A431 and TZM-bl cells incubated overnight with cell free YU2 (R5) and used to produce viral cDNA. This was
then used as a template in a nested PCR to detect a 2 Kb region of HIV pol. (D) Percentage reduction in detection of immobilized virus on the cell
surface by flow cytometry after trypsin treatment. Virally exposed cells are compared with cells labelled with secondary antibody alone. Data set is
representative of three independent experiments. * = P,0.05.
doi:10.1371/journal.pone.0098077.g003
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Figure 4. Post-integration HIV-1 mRNA transcription and de novo viral protein production in epithelial cells (MOI: 0.2). (A) Detection
of spliced HIV-1 tat mRNA in TR146, FaDu, A431 and TZM-bl control cells by PCR 24 h post-infection with YU2 (R5) or LAI (X4) infectious virus. Equal
amounts of total RNA was used to synthesise viral cDNA which was then subjected to PCR using primers designed to span the TAT 1 and 2 exon
junctions. (B) p55 gag protein detection in TR146, FaDu, A431 and TZM-bl control cells by Western blot after 24 h infection with R5 (YU2) and LAI (X4)
virus. (C) Infection of TR146, FaDu, A431 and NP2-R5/X4 control cells with GFP-linked single-cycle X4, R5 and dual tropic HIV-1 gp160 pseudotyped
virus and detection of GFP incorporation into epithelial cell DNA by flow cytometry. Error bars show standard error from the mean. Data are
representative of three independent experiments.
doi:10.1371/journal.pone.0098077.g004
Table 2. Detection of integrated HIV-1 genome in epithelial cells by qPCR.
Cell line R5-YU2 (MOI =7.5) X4-LAI (MOI =10) X4-LAI (MOI =140)
FaDu ND Not included ND
TR146 ND ND ND
A431 ND ND ND
C8166a n/a + (Ct = 33) + (Ct = 33)
NP2-R5b + (Ct = 29) n/a n/a
aC8166 cells express CXCR4 and were used for X4 viral infections only.
bNP2-R5 cells express CCR5 and were used for R5 viral infections only.
+, Integrated HIV-1 product detected (cycle threshold detection in brackets).
ND, Integrated HIV-1 product not detected.
Real-time PCR assay to detect integrated HIV-DNA using HIV-1 LTR and human Alu-specific primers and a U5 specific probe [92]. TR146, FaDu, A431 and PM-1 (control)
cells were exposed to YU2 (R5) or LAI (X4) virus for 48 h at 37uC. DNA was extracted, digested with DpnI to degrade any plasmid DNA contaminant and analysed by real-
time PCR.
doi:10.1371/journal.pone.0098077.t002
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were then transferred onto TZM-bl indicator cells for 48 h. Any de
novo virus production and subsequent infection of TZM-bl cells
would cause HIV-LTR driven b-galactosidase production, which
would be visible as blue foci in the assay. However, no blue foci
were observed. Furthermore, p24 protein in culture supernatants
was also absent at day 7 (data not shown). Together the data
indicate that no new virions were produced after prolonged virus
incubation in oral or vaginal epithelial cells.
Fourth, we utilized the three-plasmid expression system
developed by Naldini et al [94] to generate HIV-based vectors
pseudotyped with HIV-1 envelopes, HXB (X4), YU2 (R5) or 89.6
(dual tropic). Supernatants containing replication defective retro-
viral particles were used to transduce TR146, FaDu, A431 and
NP2-R5/X4 cells. NP2 cells were used as the positive control
because the receptor expression is maintained using selective
media and thus efficiency of viral infection was greater than with
TZM-bl cells. Unlike the HIV canonical receptor expressing NP2
cells, TR146, FaDu and A431 cells failed to drive expression of the
GFP reporter gene resulting in undetectable GFP fluorescence up
to 48 h post-infection (Figure 4C). Taken together, our extensive
data sets indicate that productive HIV-1 infection does not occur
in oral or vaginal epithelial cells.
HIV-1 integration into epithelial cells
Although both R5 and X4 virus was unable to productively
infect TR146, FaDu or A431 cells, it was possible that, post-
capture, HIV-1 was able to gain entry and integrated into the
epithelial cell DNA to establish a latent infection. To test for this
possibility we performed a real-time PCR assay to detect
integrated viral DNA using primer sets specific for HIV-1 LTR
and human Alu sequences with a FAM-TAMRA probe specific
for the U5 region of the LTR [92]. Initial experiments performed
at an MOI of 1 indicated no integration by R5 or X4 virus in any
epithelial cell line after 48 h (data not shown). Further experiments
demonstrated that increasing the MOI to 7.5 (X4) and 10 (R5) also
failed to permit integration into TR146, FaDu or A431 cells,
whereas in the control cell lines (NP2-R5 and C8166) amplifica-
tion of the integration product was detected after 29 and 32 cycles,
respectively (Table 2). To confirm that lack of viral integration into
the epithelial cell genome was not due to the presence of
insufficient amounts of HIV-1, a final experiment using X4 virus
at an MOI of 140 was performed, which also failed to produce
detectable levels of HIV-1 integration (Table 2). These data
demonstrate that HIV-1 X4 and R5 do not integrate into the oral
or vaginal epithelial genome.
Productive HIV-1 infection is not restricted when HIV-1
enters via the endocytic pathway
Although R5 and X4 virus does not integrate and establish a
productive infection in TR146, FaDu and A431 cells, we sought to
determine whether epithelial cells possessed the cellular machinery
to support productive infection if conventional receptor-mediated
entry mechanisms were by-passed. Therefore, we utilized the same
three-plasmid expression system as described above [94] to
generate VSV-G protein-pseudotyped HIV-1 vectors encoding
GFP. By utilizing the endocytic entry of VSV-G, strong GFP
fluorescence was observed by flow cytometry in TR146 (22%),
FaDu (38%) and A431 cells (32%) epithelial cells, at levels only
moderately lower than TZM-bl cells (50%) (Figure 5). The
differences in infection efficiency between the cell lines may be due
to the different growth rates of TR146, FaDu and A431 cells.
Importantly, the data indicate that epithelial cells are able to
support productive HIV-1 infection if HIV-1 enters via the
endocytic pathway. Addition of the HIV-1 reverse transcriptase
inhibitor AZT abolished GFP fluorescence with the VSV-G
pseudotyped virus, indicating the specificity of HIV-1 production
in both epithelial cell types.
HIV-1 transfer from epithelial cells to permissive cells
One proposed mechanism of HIV-1 transmission across
mucosal surfaces is via transfer of infections virus to underlying
permissive cells post-capture by epithelial cells. Given that both R5
and X4 virus can be captured by oral and vaginal epithelial cells
(Figure 3) but does not result in integration (Table 2) or productive
viral infection (Figure 4), we next determined whether immobi-
lized HIV-1 remained infectious post-capture. TR146, FaDu and
A431 cells were incubated with R5 and X4 virus for 24 h to allow
for viral binding and following extensive washing, TZM-bl
indicator cells were added for up to a further 48 h. Transfer of
virus from TR146, FaDu and A431 cells to TZM-bl cells and their
subsequent infection would result in b-galactosidase activation and
Figure 5. HIV-1 entry via the endocytic pathway results in
productive viral infection in epithelial cells. Two fold serial
dilutions of VSV-G pseudotyped HIV-1 (MOI 1 –0.125) were added to
TR146, FaDu, A431 and TZM-bl control cells. Infection is measured 16–
24 h later by flow cytometry as percentage of GFP expression. The
effect of AZT (500 mM) on GFP expression was also measured at the
highest virus inoculum. Error bars show standard error from the mean.
Data are representative of three independent experiments
doi:10.1371/journal.pone.0098077.g005
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the appearance of blue foci. Figure 6 indicates the presence of blue
foci, which demonstrates that R5 and X4 virus can be transferred
from both oral and vaginal epithelial cells to permissive cells.
Experiments were performed with additional controls including
absence of HIV-1 and incubation of TZM-bl cells with
conditioned medium, none of which resulted in the appearance
of blue foci, indicating that the blue foci were the result of R5 and
X4 transfer from the epithelial cells.
HIV-1 transcytosis across epithelium
Another proposed mechanism of HIV-1 transmission is via
transcytosis across epithelial barriers to infect underlying permis-
sive cells. To test this, we developed a transwell system, similar to
the method developed by Nazli et al [59], in which R5 and X4
virus that had bound to epithelial cells was separated from
permissive TZM-bl cells by an inert membrane. HIV-1 was only
capable of infecting the TZM-bl cells if the virus transcytosed
across the epithelial cells and through the membrane pores
(0.4 mm). Dextran blue was added to all cultures to ensure that the
epithelial monolayer remained confluent and that virus did not
migrate between ’gaps’ in the epithelial cells to the underlying
TZM-bl compartment (Figure S3). After 48 h incubation at 37uC,
HIV-1 was capable of infecting TZM-bl as demonstrated by the
presence of blue foci (Figure 7). The colony counts resulting from
exposure of epithelium to X4 (p = 0.036) and R5 (p= 0.001) were
significantly greater than control wells with no virus exposure, but
were not significantly different from each other. Furthermore,
transcytosis through A431 epithelial cells was significantly greater
than through TR146 (p = 0.038) and FaDu (p = 0.030) epithelial
cells. This demonstrates that HIV-1 is capable of transcytosing
across epithelial cells to infect underlying permissive cells and that
transcytosis is more efficient across the vaginal epithelium.
It should be noted that a very small amount of blue foci were
observed in the absence of HIV-1 (Figure 7). The HIV-1 LTR
possesses NF-kB and AP-1 transcription factor binding sites
(among other sites). Given that cytokines and growth factors are
constitutively produced by resting epithelial cells, low level HIV-1
LTR activation can sometimes be observed (‘leakiness’) in the
absence of virus. However, in the presence of HIV-1, cellular
transcription factors and machinery at the HIV-1 LTR are
stabilised by tat allowing for a greater and more consistent increase
in signal, as observed.
Discussion
The majority of HIV-1 infections worldwide are acquired via
mucosal surfaces. Transmission is predominantly across the female
genital tract [1], with oral transmission across the oral mucosa
being more uncommon [26]. However, given that the oral cavity is
a prime site for HIV-1 transmission in nursing infants and during
oral-genital contact, it is profoundly important to understand the
fate of HIV-1 after exposure to both vaginal and oral tissues and to
determine whether differences exist at the two sites. One view is
that HIV-1 can directly infect epithelial cells with low efficiency,
Figure 6. Transfer of captured HIV-1 from epithelial cells to permissive cells via cell-cell contact. TR146, FaDu and A431 cells were
incubated with R5 (YU2) and LAI (X4) virus for 24 h and following extensive washing TZM-bl indicator cells were added for a further 48 h. Controls
included FaDu, TR146 and A431 cells without the addition of virus. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0098077.g006
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thereby establishing a primary infection. Another view is that
HIV-1 is captured by epithelial cells and is subsequently
transferred to permissive cells in the sub-mucosa either directly
from the surface or after transcytosis across epithelial cells. In this
study we compared both mucosal sites using identical assay
systems to study the fate of HIV-1 R5 and X4 virus after exposure
to buccal (TR146), pharyngeal (FaDu) and vulvovaginal (A431)
epithelial cells. A431 epithelial cells have different reported origins
(vaginal epithelial or epidermal) but are routinely used to represent
the vaginal mucosa [83–87]. Our work strongly supports the
second view, whereby oral and vaginal epithelial cells are able to
capture and subsequently transfer infectious virus to permissive
cells but that viral genome integration and other markers for
infectious virus production, such as mRNA transcription and viral
protein production, do not occur. However, epithelial cells possess
the cellular machinery to support HIV-1 replication since the
above-mentioned post-entry processes are not restricted if
conventional HIV-1 entry is circumvented through VSV-G
mediated endocyctic pathways. Therefore, we propose that oral
and vaginal epithelial cells may play an important function in
HIV-1 dissemination through their ability to bind HIV-1 and
transfer viable virus to permissive cells, which in vivo would permit
infection of immune cells in the sub-mucosa and establishment of a
primary HIV-1 infection.
Using qualitative and quantitative analyses we demonstrate that
both R5 and X4 virus are able to bind directly to TR146, FaDu
and A431 epithelial cells. Binding appears to be independent of
canonical HIV-1 receptor expression, since low or undetectable
levels of CD4, CCR5 and CXCR4 expression were found in both
oral and vaginal epithelial cell types, which is in concordance with
most studies investigating epithelial expression of these receptors
[27,39,40,45–47,69,70]. This also supports studies with primary
epithelial cells using inhibitors and neutralising antibodies, which
indicate that HIV-1 binding is independent of CD4, CXCR4 and
CCR5 [46]. Rather, given their higher surface expression, viral
binding is probably mediated via non-canonical receptors such as
GalCer and HSPG’s (e.g. syndecans) but unlikely to be via DC-
SIGN, which was expressed at very low levels in all cell types.
Although some studies have suggested that HSPGs rather than
GalCer are the key moieties involved in HIV-1 binding to vaginal
epithelial cells [46], we found no correlation between increased
viral binding with GalCer or HSPG expression in either epithelial
cell type. However, we did correlate increased viral binding in
FaDu cells with trypsin sensitivity, indicating that FaDu cells may
utilize additional surface moieties for viral biding than TR146 or
A431 cells.
The utilization of both protein (e.g. HSPG) and non-protein
(e.g. GalCer) moieties by HIV-1 to bind epithelial cells is
supported by the fact that R5 and X4 binding was reduced but
not abolished after trypsin digestion. Notably, X4 virus may
preferentially utilize non-protein moieties since a greater number
of X4 virus remained attached after trypsin digestion as compared
with R5 virus. The reason for this X4 trypsin resistant binding is
unclear but may reflect the utilisation of different regions of X4
and R5 gp120 to bind various target receptors or, alternatively, X4
virus may somehow preferentially be protected over R5 virus by
other epithelial structures on the surface. While most primary
HIV-1 infections occur with R5 virus [95] and some studies have
found a preference for R5 selection in oral epithelial cells via cell-
associated [70] and cell-free systems [69], our extensive binding
data indicate no such preference in vaginal, buccal and pharyngeal
epithelial cells as both R5 and X4 virus appear to bind equally
well.
Whether viral entry and genome integration occurs in epithelial
cells is unclear, but this may be reflective of the variety of
experimental approaches and procedures used in different studies.
One study using immortalized OKF6/TERT-2 oral cells (floor of
mouth) showed that HIV-1 may directly integrate into epithelial
cells without establishing a productive infection [41]. However, the
lack of DNAse treatment of virus stocks prior to infection or DpnI
treatment of DNA samples after infection may not have been
sufficient to remove potential plasmid contamination. Although
nuclear extracts were used and heat-inactivated controls included,
this may not have been sufficient to prevent false positives for viral
integration. Another study detected proviral HIV-1 DNA in
between 29–68% vaginal and cervical clinical samples, indicating
viral integration [64]. However, the samples may have included
immune cells that were present in mucosa or secretions at the time
of collection, especially since bleeding was observed in approxi-
mately 50% of patients upon cervical sample collection. A separate
study detected proviral HIV-1 DNA in three carcinoma cell lines
(HEC1A, endometrium; CaSki, cervix; SiHa, uterus) and primary
vaginal epithelial cells [45] and noted a preference for X4
integration, since all these cells expressed high amounts of
CXCR4 (,60%) and SDF-1 (a CXCR4 ligand) blocked
integration. Studies with primary gingival [38] and uterine [96]
epithelial cells have also demonstrated preferential integration of
X4 virus, probably because of high surface expression of CXCR4
and GalCer, which together can be used as alternative receptors to
CD4 for viral entry [38]. However, other studies have failed to
observe HIV-1 gag DNA in primary cervical epithelial cells or the
cervical ME-180 cell line [47], or the ectocervix cell line (Ect1/
E6E7) despite HIV-1 being captured and subsequently released
[55]. The latter study further confirmed a lack of viral integration
using a luciferase reporter virus expressing CCR5 gp120 envelope.
Using a sensitive real-time PCR assay that measures the amount
of carry-over DNA, as all samples are quantified relative to a
matched heat-inactivated control, we provide strong evidence that
Figure 7. Transfer of captured HIV-1 from epithelial cells to
permissive cells via transcytosis. TR146, FaDu and A431 were
grown on polycarbonate transwell membranes and incubated with R5
(YU2) and LAI (X4) virus for 4 h. Following extensive washing the
transwells were placed in a separate plate that overlaid a confluent
monolayer of TZM-bl cells and incubated for a further 48 h at 37uC.
TZM-bl cells were fixed, stained for b-galactosidase expression with X-
Gal stain, and counted using light microscope at 100x magnification.
Resulting replicate colony counts were averaged and analyzed by two
factor (cell line and virus tropism) ANOVA and post hoc Fisher PLSD
tests. Colony counts through A431 monolayers were significantly
greater than those through TR146 and FaDu (P,0.05). Colony counts
resulting from exposure of epithelium to X4 and R5 were significantly
greater (P,0.05) than control wells with no virus exposure, but were
not significantly different from each other. Data are representative of
three independent experiments. * P,0.05.
doi:10.1371/journal.pone.0098077.g007
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both R5 and X4 virus are unable to integrate their genomes into
the DNA of oral or vaginal epithelial cells. One explanation for
this may be the very low surface expression levels of CXCR4 in
TR146, FaDu and A431 cells (,5%). In this regard, the origin of
A431 cells (vulval), which is different to those vaginal epithelial
cells used in the above studies, may account for the differences in
CXCR4 expression and hence X4 viral integration. Another
explanation may be that, unlike the above studies, our samples
were rigorously treated with DNAse and DpnI digestion to prevent
the detection of possible false positive integration events.
Interestingly, another study showed that HIV-1 proviral DNA
could be detected in differentiated colonic epithelial cell clones but
not undifferentiated clones [63]. If applicable to vaginal epithelial
cells, this may have implications for HIV-1 transmission in vivo, as
the virus may more readily integrate into apical (differentiated)
rather than basal (undifferentiated) epithelial cells. This may
provide an additional explanation for why proviral DNA was not
detected in A431 cells as they are an undifferentiated cell line [97].
To further study the fate of the virus after binding to oral and
vaginal epithelial cells and to determine whether HIV-1 can
productively infect epithelial cells, we employed three different
approaches: infection with HIV-1 gp160 pseudotyped virus,
detection of spliced HIV-1 tat mRNA, and de novo production of
p55 gag protein. Using these approaches we demonstrate that
HIV-1 infection, de novo HIV-1 protein production and viral
assembly are not supported in either epithelial cell type. These
observations, together with the general absence of CD4/CXCR4/
CCR5 expression in both oral and vaginal epithelial cells, support
the view that productive HIV-1 infection requires canonical
receptor expression on the host cell. Our findings are in
concordance with the majority of other studies demonstrating a
lack of productive HIV-1 infection in epithelial cells despite the
presence of HSPGs and GalCer [17,20,47,55,98]. However, they
are in contrast with other studies demonstrating productive viral
infection in epithelial cell lineages isolated from tonsilar tissue [71–
73], adenoids [69], salivary glands [70,74] primary gingival
keratinocytes [38,69] and vaginal epithelial cells [5,61–63].
Notably, the findings of the above studies indicating infection
appear to correlate with greater expression of CXCR4 and/or
GalCer than that found in our study. Finally, the in vivo relevance of
one study demonstrating productive infection of X4 virus but not
R5 virus in primary gingival cells [38] was questioned by Quinones-
Mateu [40], as it used the artificial compound polybrene to promote
HIV-1 viral entry into the epithelial cell (see below).
As noted above we have also demonstrated that trypsin
treatment failed to remove all surface-bound HIV-1. This raises
an important issue with regard to other co-culture studies [41,99]
that have claimed infection of permissive cells as a result of de novo
virus production in epithelial cells. In these studies it is possible
that new viral progeny may have originated from trypsin-resistant
bound HIV-1, which was transferred to the permissive cells from
the epithelial cell surface leading to their infection, and not from de
novo virus production in epithelial cells.
Several studies have reported that HIV-1 may be sequestered in
cytosolic endocytic compartments [1,46,77,79,80,100], which may
result in productive infection. Whilst one study showed that HIV-1
released in vesicles by infected T-cells were taken up by cervical
(ME100) carcinoma epithelial cells resulting in productive
infection [62], another study showed a lack of productive infection
after 18 days despite integrated proviral DNA being present [45].
To address whether HIV-1 entry via endocytosis results in
productive infection we utilized a GFP-encoding VSV-G pseudo-
typed HIV-1 virus, which utilizes the endocytic pathway for cell
entry and by-passes conventional CD4 receptor-mediated entry.
This virus was able to establish a productive infection in TR146,
FaDu and A431 cells that could be inhibited with AZT,
demonstrating that HIV-1 binding in epithelial cells is probably
mediated through non-canonical receptors and epithelial cells are
able to assemble and secrete infectious viral progeny if receptor-
mediated entry is by-passed. Together with the fact that HIV-1
infection of TZM-bl cells (epithelial-like cells expressing CD4,
CXCR4 and CCR5) also results in the assembly and secretion of
infectious viral progeny, our data suggests that oral and vaginal
epithelial cells are able to support productive viral infection, but
only if HIV-1 gains entry into the cell through non-conventional
(endocytic) mechanisms. This may explain why the use of polybrene
led to productive HIV-1 infection in primary gingival epithelial cells
[38] (see above). Our findings raise the intriguing possibility that if
conditions arise in vivo that enable receptor-mediated entry to be by-
passed, for example during inflammatory responses, productive
HIV-1 infection may be supported in epithelial cells [101].
We propose that under ’normal’ conditions it is unlikely that
HIV-1 binding results in productive viral infection in epithelial
cells. However, post-capture, infectious virus may remain immo-
bilized on the surface giving rise to the possibility of transmission
to permissive cells in the underlying mucosa either through direct
cell-cell transfer or via viral transcytosis across the epithelial cell. A
number of studies support this hypothesis [7–14,16–18,47,57,102],
although others could not demonstrate viral transfer to permissive
cells (PBMCs) by cell-cell contact [45]. Utilizing an overlay
experiment we show that HIV-1 retains infectivity on the epithelial
cell surface and can be readily transferred to TZM-bl cells via
direct cell-cell contact to establish a productive infection. We also
demonstrate using a transwell system that HIV-1 can transcytose
across oral and vaginal epithelial cells to infect TZM-bl cells
separated from the epithelium by a permeable membrane.
Transfer of virus to permissive cells has also been observed for
other oral epithelial cell lineages [38,41,55,78] and appears to
occur in a CD4/CCR5/CXCR4 and GalCer independent
manner. Although we are uncertain of the surface moieties that
enable binding and transfer, others have demonstrated an
important role for HSPGs, since heparin or heparin sulfate can
inhibit gp120 binding to CD4 cells and heparinase treatment can
reduce viral attachment [54,55,103,104]. These findings have
implications for HIV-1 infection in vivo as this may provide a
window of opportunity for infectious immobilized virus to be
transferred to susceptible immune cells in the sub-mucosa, thereby
establishing an acute infection and disseminating the virus in the
body. This is supported by both macaque and human studies,
which indicate that viral transmission is facilitated by the presence
of HIV-1 target cells (dendritic cells, Langerhans cells, CD4+ T
cells and macrophages) in the uterus, endocervix, ectocervix and
vagina [7–21,96]. Furthermore, systemic viral dissemination can
be observed 24 h after atraumatic exposure of the oral mucosa to
SIV-1 [36]. In addition, using ex vivo tissue explants Tugizov et al.
[81,82] recently demonstrated that HIV-1 efficiently transcytoses
through adult and fetal polarized oral epithelial cells, although
only virions emerging after transcytosis from fetal epithelial cells
appeared to be infectious. Our data are in agreement with the
latter studies indicating viral transcytosis through oral and vaginal
epithelial cells but additionally that HIV-1 remains infectious
enabling transfer to permissive cells basally.
We note that our data is based on cell lines and does not mimic
the pluristratified, thre-dimensional structure of the buccal
mucosa. However, despite these limitations, our data conform to
primary cell studies and support the view that HIV-1 is readily
captured by epithelial cells but that genome integration and
productive viral infection does not occur. However, epithelial cells
Epithelial Cells Binding and Transfer Infectious HIV-1
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possess the cellular machinery to support productive HIV-1
infection if the virus enters via the endocytic pathway or if
conventional entry mechanisms are by-passed. Once captured,
HIV-1 also remains infectious on the surface of epithelial cells,
which may facilitate viral transfer to permissive cells (e.g. dendritic
cells, Langerhans cells, tissue macrophages) in the sub-mucosa
either directly from the epithelial surface or after transcytosis
through the epithelium, thereby establishing acute infection.
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